| Generic Name | Metoclopramide |
|---|---|
| Drug Class | Dopamine (D₂) Receptor Antagonist 5-HT4 Agonist / 5-HT3 Antagonist (weak) |
| Indications |
|
| Mechanism of Action | Blocks dopamine (D₂) receptors centrally and peripherally, enhances acetylcholine release in the gut, increases gastric emptying, and acts on the chemoreceptor trigger zone. |
| Available Forms & Strengths | • Tablet: 10 mg • Oral syrup • Injection: 5 mg/mL |
| Dosage | Adults: 10 mg up to 3 times daily (before meals) Children: 0.1–0.15 mg/kg per dose, max 10 mg |
| Route | Oral, IV, IM |
| Common Side Effects |
|
| Serious Adverse Effects | Extrapyramidal symptoms, tardive dyskinesia, neuroleptic malignant syndrome (rare) |
| Contraindications | • Pheochromocytoma • Epilepsy • GI obstruction, perforation, or hemorrhage |
| Precautions | • Children and young adults (↑ EPS risk) • Parkinson’s disease • Renal impairment |
| Drug Interactions | • Antipsychotics (↑ EPS risk) • Levodopa (↓ effect) • CNS depressants |
| Pregnancy & Lactation | Pregnancy: Generally considered safe Lactation: Use with caution (may ↑ prolactin) |
| Storage | Store below 30°C, protect from light |
| References | BNF | BNF for Children | Nelson Textbook of Pediatrics |